146 related articles for article (PubMed ID: 37969677)
1. Clinicopathological Significance and Prognostic Role of Her2neu Protein Expression in Patients with Carcinoma Stomach: A Prospective Study from Northern India.
B AV; Behera MK; Patne SCU; Shukla SK; Dixit VK
South Asian J Cancer; 2023 Apr; 12(2):135-140. PubMed ID: 37969677
[TBL] [Abstract][Full Text] [Related]
2. Role of HER2neu expression in gastric cancer.
Sukanya JS; Raj PV; Thanka J
Indian J Pathol Microbiol; 2021; 64(1):58-64. PubMed ID: 33433410
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Variation of Lauren Classification in Gastric Cancer.
Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH
Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923
[TBL] [Abstract][Full Text] [Related]
4. Expression of PDL1 and Her2neu in Gastric and Gastroesophageal Junction Adenocarcinoma.
Saurabh A; Raphael V; Dey B; Harris C; Jagtap V; Das U
Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):144-151. PubMed ID: 33994740
[TBL] [Abstract][Full Text] [Related]
5. Y-Box binding protein 1 expression in breast cancer and its correlation with hormone receptors and other prognostic markers.
Bansal T; Tanveer N; Singh UR; Sharma S; Kaur N
J Lab Physicians; 2018; 10(4):420-425. PubMed ID: 30498315
[TBL] [Abstract][Full Text] [Related]
6. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
[TBL] [Abstract][Full Text] [Related]
7. Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India.
Nadaf AS; Rani H; Dinesh US
Asian Pac J Cancer Prev; 2018 May; 19(5):1381-1385. PubMed ID: 29802704
[TBL] [Abstract][Full Text] [Related]
8. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
9. HER2 Expression in Gastric Adenocarcinoma-a Study in a Tertiary Care Centre in South India.
Aditi R; Aarathi R; Pradeep R; Hemalatha L; Akshatha C; Amar K
Indian J Surg Oncol; 2016 Mar; 7(1):18-24. PubMed ID: 27065677
[TBL] [Abstract][Full Text] [Related]
10. Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071).
Moehler M; Schad A; Maderer A; Atasoy A; Mauer ME; Caballero C; Thomaidis T; John JMM; Lang I; Van Cutsem E; Freire J; Lutz MP; Roth A;
Cancer Chemother Pharmacol; 2018 Oct; 82(4):733-739. PubMed ID: 30105460
[TBL] [Abstract][Full Text] [Related]
11. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.
Han K; Nofech-Mozes S; Narod S; Hanna W; Vesprini D; Saskin R; Taylor C; Kong I; Paszat L; Rakovitch E
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):183-9. PubMed ID: 21958729
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren's Classification.
Pyo JH; Ahn S; Lee H; Min BH; Lee JH; Shim SG; Choi MG; Lee JH; Sohn TS; Bae JM; Kim KM; Yeon S; Jung SH; Kim JJ; Kim S
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):784-791. PubMed ID: 27613552
[TBL] [Abstract][Full Text] [Related]
13. Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer.
Bădescu A; Georgescu CV; Vere CC; Crăiţoiu S; Grigore D
Rom J Morphol Embryol; 2012; 53(4):997-1005. PubMed ID: 23303024
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of HER2Neu Status in Periampullary Cancers in Tertiary Care Centre in Northern India: A Three-Year Retrospective Study.
Qayoom S; Agarwal A; Agarwal P; Anand A; Raj R; Gupta S; Singh A
Cureus; 2023 Oct; 15(10):e46646. PubMed ID: 37937013
[TBL] [Abstract][Full Text] [Related]
15. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.
Haroon S; Hashmi AA; Khurshid A; Kanpurwala MA; Mujtuba S; Malik B; Faridi N
Asian Pac J Cancer Prev; 2013; 14(7):4353-8. PubMed ID: 23992002
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis.
Allgayer H; Babic R; Grützner KU; Beyer BC; Tarabichi A; Wilhelm Schildberg F; Heiss MM
Cancer; 1997 Jul; 80(2):179-87. PubMed ID: 9217027
[TBL] [Abstract][Full Text] [Related]
17. CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.
Li L; Fu LQ; Wang HJ; Wang YY
Pathol Oncol Res; 2020 Jan; 26(1):273-279. PubMed ID: 30047046
[TBL] [Abstract][Full Text] [Related]
18. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Raţiu I; Vernic C
Rom J Morphol Embryol; 2010; 51(2):249-57. PubMed ID: 20495739
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CD44 and c-erb-B2 protein overexpression in patients with gastric cancer.
Doventas A; Bilici A; Demirell F; Ersoy G; Turna H; Doventas Y
Hepatogastroenterology; 2012 Oct; 59(119):2196-201. PubMed ID: 23435135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
